Top Health-care stocks:
Health-care shares were mainly lower in early trade on Monday.
In health-care stocks news, Verona Pharma ( VRNA ) said Monday it has started a clinical pharmacokinetic trial in the United States for its product candidate, RPL554, following the acceptance of an Investigational New Drug application by the U.S. Food and Drug Administration.
Shares in the company were unchanged at $13.50 in early trade. The stock has traded between $11.05 and $17.50 over the past 52 weeks.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.